SearcharxivSearch

arXiv subjects

Daniel Rabinowitz

Publications and source records attributed to Daniel Rabinowitz.

2 recordsLinked to original sources

Optimal Designs of Two-Phase Case-Control Studies for General Predictor Effects

Under two-phase designs, the outcome and several covariates and confounders are measured in the first phase, and a new predictor of interest, which may be costly to collect, can be measured on a subsample in the second phase, without incurring the costs of recruiting subjects. By using the information gathered in the first phase, the second-phase subsample can be selected to enhance the efficiency of testing and estimating the effect of the new predictor on the outcome. Past studies have focused on optimal two-phase sampling schemes for statistical inference on local ($\beta = o(1)$) effects of the predictor of interest. In this study, we propose an extension of the two-phase designs that employs an optimal sampling scheme for estimating predictor effects with pseudo conditional likelihood estimators in case-control studies. This approach is applicable to both local and non-local effects. We demonstrate the effectiveness of the proposed sampling scheme through simulation studies and analysis of data from 170 patients hospitalized for treatment of COVID-19. The results show a significant improvement in the estimation of the parameter of interest.

stat.ME

Efficiency in Lung Transplant Allocation Strategies

Currently in the United States, lung transplantations are allocated to candidates according to the candidates' Lung Allocation Score (LAS). The LAS is an ad-hoc ranking system for patients' priorities of transplantation. The goal of this study is to develop a framework for improving patients' life expectancy over the LAS based on a comprehensive modeling of the lung transplantation waiting list. Patients and organs are modeled as arriving according to Poisson processes, patients' health status evolving a waiting time inhomogeneous Markov process until death or transplantation, with organ recipient's expected post-transplant residual life depending on waiting time and health status at transplantation. Under allocation rules satisfying minimal fairness requirements, the long-term average expected life converges, and its limit is a natural standard for comparing allocation strategies. Via the Hamilton-Jacobi-Bellman equations, upper bounds for the limiting average expected life are derived as a function of organ availability. Corresponding to each upper bound is an allocable set of (time, state) pairs at which patients would be optimally transplanted. The allocable set expands monotonically as organ availability increases, which motivates the development of an allocation strategy that leads to long-term expected life close to the upper bound. Simulation studies are conducted with model parameters estimated from national lung transplantation data. Results suggest that compared to the LAS, the proposed allocation strategy could provide a 7.7% increase in average total life. We further extended the results to the the allocation and matching of multiple organ types.

stat.AP